Skip to main content
Search
Main content
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published

Quantitative susceptibility mapping of the brain is associated with inflammatory changes in Alzheimer's disease related areas

Authors

Seyyed Ali Hosseini, Stijn Servaes, Arthur C Macedo, Etienne Aumont, Nesrine Rahmouni, Tevy Chan, Joseph Therriault, Lydia Trudel, Brandon Hall, Yi-Ting Wang, Jaime Fernandez Arias, Gleb Bezgin, Yansheng Zheng, Marina P Gonçalves, Kely Quispialaya Socualaya, Marcel S Woo, Cécile Tissot, Delphine Oliva-Lopez, Jieying Li, Stuart Mitchell, Aurélie Lebrun, Robert Hopewell, Sanjeev Chawla, Vladimir Fonov, Gassan Massarweh, Yasser Iturria Medina, Jean-Paul Soucy, Maxime Montembeault, Paolo Vitali, Kaj Blennow, Thomas K Karikari, Andréa L Benedet, Nicholas J Ashton, Henrik Zetterberg, Tharick A Pascoal, Serge Gauthier, Jesse Klostranec, Hangwei Zhuang, Junghun Cho, D Louis Collins, Yi Wang, David A Rudko, Pedro Rosa-Neto

Abstract

J Cereb Blood Flow Metab. 2026 Feb 8:271678X261417193. doi: 10.1177/0271678X261417193. Online ahead of print.

ABSTRACT

Accumulation of paramagnetic substances in brain tissue may constitute a feature of Alzheimer's disease (AD) associated with inflammatory processes. This study employed MRI quantitative susceptibility mapping (QSM), as an index of paramagnetic load, to assess its association with brain Aβ and tau aggregates, as well as inflammatory biomarkers. We assessed QSM and T1-weighted MRI scans from 315 participants in the TRIAD cohort, including young-controls and individuals across the AD spectrum. Imaging was performed at baseline, with follow-up assessments at 12 and 24 months. Mean-cortical and subcortical susceptibility values were measured, and correlations with AD-relevant plasma and CSF inflammatory biomarkers. At baseline, AD patients had significantly greater QSM than age-matched controls in the posterior cingulate cortex, precuneus, and basal ganglia. After 24 months, QSM increased in the anterior cingulate in MCI, while dementia cases showed increase in the pallidum and hippocampus. Multiple comparison analysis indicated correlation between QSM and immune biomarkers IL-10RB, PD-L1, SCF, TWEAK, CSF-1, CXCL9, HGF, and CD40, but not with brain Aβ or tau-related biomarkers. Our findings reveal that the magnitude of tissue susceptibility load, as measured by QSM, reflects tissue inflammation rather than protein aggregation. QSM provides new insights into tissue dysfunction, with potential applications in AD therapeutic development.

PMID:41656561 | DOI:10.1177/0271678X261417193

UK DRI Authors

Profile picture of Henrik Zetterberg

Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Prof Henrik Zetterberg